Clinical Nurse Specialist, Psychiatric/Mental Health · New Haven, CT
NPI
1477127587
Since 2021
Specialty
Clinical Nurse Specialist, Psychiatric/Mental Health
Code 364SP0808X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
20 York St
New Haven, CT, 06510
Phone (646) 519-1853
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,229
52 services
Medicare patients, 2024
23
Average age 64
Drug cost, 2024
$32K
215 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maja Witwicka was code 99407 (behavioral health services), 43 times for 20 patients. In total Maja Witwicka billed 52 services in 1 codes, and Medicare paid $1,229.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99407 Behavioral Health Services | Office | 43 | 20 | $24.06 | $1,035 |
By year: 2023 $932 for 31 services; 2024 $1,229 for 52 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maja Witwicka prescribed most often to Medicare patients was Varenicline Tartrate, with 137 prescriptions and refills. In total Maja Witwicka wrote 215 Medicare prescriptions that cost $32K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Varenicline Tartrate Generic | 137 | 149 | 62 | $31K |
| Bupropion Hcl Sr Bupropion Hcl | 43 | 50 | 16 | $670 |
| Bupropion Xl Bupropion Hcl | 12 | 14 | Under 11 | $210 |
| Escitalopram Oxalate Generic | 11 | 13 | Under 11 | $40.88 |
Brand drugs: 0 claims; generic drugs: 215 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Maja Witwicka were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.